Oct 17 (Reuters) - InMed Pharmaceuticals Inc IN.CD
* InMed Pharmaceuticals Inc - announced additional pre-clinical results in development of INM-405 for treatment of pain
* InMed Pharma- results show peripheral application of some cannabinoid compounds effective in treating craniofacial muscle pain disorders, without observed CNS side effects